|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2024―Jul―09 |
Impact of the COVID-19 pandemic on psychosocial health in rheumatic patients: A longitudinal study |
Laura Cano-García, Sara Manrique-Arija, Rocío Redondo-Rodríguez, Marta Vera-Ruiz, Jose Manuel Lisbona-Montañez, Arkaitz Mucientes-Ruiz, et al. (+4) Aimara García-Studer, Fernando Ortiz-Marquez, Natalia Mena-Vázquez, Antonio Fernández-Nebro |
2 |
[GO] |
2024―Mrz―16 |
The impact of COVID-19 and other factors on the usage status of the biologic drug therapies for rheumatoid arthritis: A study from Vietnam |
Hai-Binh Bui, Hong-Thinh Lai, Thanh-Lam Nguyen, Thuy-Duong Vu, Nhat-Le Bui, Van-Hung Nguyen, et al. (+5) Thi-To-Chau Tran, Thi-Phuong-Thuy Nguyen, Thi-Ngoc-Lan Nguyen, Jaffar A. Al-Tawfiq, Dinh-Toi Chu |
3 |
[GO] |
2023―Dez―04 |
The “autoimmune/inflammatory syndrome induced by adjuvants” (ASIA) after COVID-19 infection: A case report |
Patricia Aguilera-Fernandez, María del Carmen Navarro-Saez, Carlos Feijoo-Massó, Enrique Esteve-Valverde, Sonia Calzado Isbert, Tamara Parra Parente |
4 |
[GO] |
2023―Nov―25 |
Analysis of factors involved in the development of humoral response to vaccination against SARS-CoV-2 in patients with rheumatic pathology under biological treatment |
E. Flores-Fernández, I. Vázquez-Gomez, E. Valls-Pascual, C. Valera-Ribera, P. Andújar-Brazal, J.J. Alegre-Sancho |
5 |
[GO] |
2023―Okt―13 |
Osteomuscular and autoimmune manifestations of long COVID in Mexico |
Luis Del Carpio-Orantes, Sergio García-Méndez, Andrés Aguilar-Silva, Álvaro Efrén Munguía-Sereno |
6 |
[GO] |
2023―Jun―01 |
Comparison of the first and sixth waves of the SARS-COV-2 coronavirus pandemic in patients with immune-mediated disease |
Carmen Lobo Rodríguez, Ana M. López-Calleja, Paloma Morales de los Ríos Luna, Susana Sánchez Vázquez, Ángela Molinero Sampedro, Amparo López-Esteban |
7 |
[GO] |
2023―Mai―24 |
Systemic lupus erythematosus myocarditis and COVID-19 vaccination: Comment |
Amnuay Kleebayoon, Viroj Wiwanitkit |
8 |
[GO] |
2023―Feb―02 |
Long COVID-19 and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Correspondence |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
9 |
[GO] |
2023―Feb―02 |
Systemic lupus erythematosus myocarditis after COVID-19 vaccination |
Miguel Sogbe, Andrés Blanco-Di Matteo, I. Madeleine Di Frisco, Juan Fernando Bastidas, Nahikari Salterain, Juan José Gavira |
10 |
[GO] |
2022―Nov―24 |
Long COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome: Similarities and differences of two peas in a pod |
Rami Qanneta |
11 |
[GO] |
2022―Sep―06 |
Comment to: Teleconsultation of infant rheumatology in COVID-19 time |
Rami Qanneta |
12 |
[GO] |
2022―Jun―25 |
Comment: The reality of rheumatology in Spain and its autonomous communities before the pandemic |
Dolors Grados Cànovas, Melania Martínez-Morillo, Alejandro Olivé Marqués |
13 |
[GO] |
2022―Jun―24 |
Use of anakinra in the treatment of SARS-CoV-2 severe respiratory infection |
Luis Figuero-Pérez, Alejandro Olivares-Hernández, Roberto A. Escala-Cornejo, Juan J. Cruz-Hernández |
14 |
[GO] |
2022―Jun―22 |
Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab: comment |
Ismael Francisco Aomar-Millán, Juan Salvatierra, José Luis Callejas-Rubio, Enrique Raya-Álvarez |
15 |
[GO] |
2022―Mai―11 |
Reactive arthritis with SARS-COV-2 as a trigger |
Víctor Ruiz-del-Valle, Luis Sarabia de Ardanaz, Míriam Navidad-Fuentes, Irene Martín-Martín, Rubén Lobato-Cano |
16 |
[GO] |
2022―Mai―11 |
Calcineurin Inhibitors and COVID-19 |
René Hage, Macé M. Schuurmans |
17 |
[GO] |
2022―Apr―30 |
The reality of Rheumatology in Spain and its autonomous communities before the pandemic |
Carlos Sánchez-Piedra, José María Álvaro-Gracia, Sagrario Bustabad-Reyes, Federico Díaz-González |
18 |
[GO] |
2022―Mrz―18 |
Impact of Lung Ultrasound during the SARS-CoV-2 Pandemic: Distinction Between Viral and Bacterial Pneumonia |
Yale Tung-Chen, Alejandro Giraldo Hernández, Alberto Mora Vargas, Laura Dorado Doblado, Patricia Elsa González Merino, Ángela Valencia Alijo, et al. (+5) Jesús Herraiz Jiménez, Ángela Gutiérrez Rojas, Sonia García Prieto, Edith Vanesa Gutiérrez Abreu, Esther Montero Hernández |
19 |
[GO] |
2022―Mrz―08 |
Experience With the Use of Baricitinib and Tocilizumab Monotherapy or Combined, in Patients With Interstitial Pneumonia Secondary to Coronavirus COVID19: A Real-World Study |
José Rosas, Francisco Pasquau Liaño, Mónica Llombart Cantó, José María Carrasco Barea, Amparo Raga Beser, José Tomás Algado Rabasa, et al. (+9) Francisco Martínez Adsuar, Brian Vila Auli, Isabel Fernández López, Ana María Garijo Sainz, Pere Esquerdo Ramis, Laura Ruiz Pérez, Mª Luisa Navarrete Rebollo, Raquel Hernández Lorido, Laura Gómez Escolar |
20 |
[GO] |
2021―Dez―20 |
Recurrent pericarditis after Covid-19 |
David Rodrigo Domínguez, Amalia Rueda Cid, Cristina Campos Fernández, Clara Molina Almeda, Juan Jóse Lerma Garrido, M. Dolores Pastor Cubillo |
21 |
[GO] |
2021―Okt―29 |
Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia |
Olga Sanchez-Pernaute, Fredeswinda I. Romero-Bueno, Albert Selva-O’Callaghan |
22 |
[GO] |
2021―Sep―16 |
Characteristics of patients with immune-mediated inflammatory diseases hospitalized for SARS-CoV-2 infection |
Montserrat Robustillo-Villarino, Laura Álvarez-Arroyo, Francisco Javier Carrera-Hueso, Inés Barreda-Altaba, María Nieto-Cid, Ana María Girona-Sanz, David El-Qutob |
23 |
[GO] |
2021―Sep―09 |
Hospitalization and Mortality from COVID-19 of Patients with Rheumatic Inflammatory Diseases in Andalusia |
Natalia Mena-Vázquez, Sara Manrique Arija, Marta Rojas-Giménez, Enrique Raya-Álvarez, María Luisa Velloso-Feijoó, C. López-Medina, et al. (+7) Consuelo Ramos-Giraldez, Francisco Javier Godoy-Navarrete, Rocío Redondo-Rodríguez, Alba María Cabezas-Lucena, M. Morales-Águila, C.M. Romero-Barco, Antonio Fernández-Nebro |
24 |
[GO] |
2021―Jul―20 |
Colchicine: A potential therapeutic tool against COVID-19. Experience of 5 patients |
Giovanni Montealegre-Gómez, Edgar Garavito, Arley Gómez-López, Adriana Rojas-Villarraga, Rafael Parra-Medina |
25 |
[GO] |
2021―Jun―02 |
Tele-Rheumatology during the COVID-19 pandemic |
Jesús Tornero-Molina, Fernando Sánchez-Alonso, Manuel Fernández-Prada, María-Luisa Bris-Ochaita, Alberto Sifuentes-Giraldo, Javier Vidal-Fuentes |
26 |
[GO] |
2021―Jun―02 |
Impact of the COVID-19 pandemic on rheumatology nursing consultation |
Susana P. Fernández Sánchez, Fermín Rodríguez Muñoz, Ana Laiz, Ivan Castellví, Berta Magallares, Héctor Corominas |
27 |
[GO] |
2021―Apr―27 |
Teleconsultation of infant rheumatology in Covid-19 time |
Juan Carlos Nieto-González, Indalecio Monteagudo |
28 |
[GO] |
2021―Apr―14 |
Proposal for the use of anakinra in acute respiratory distress secondary to COVID-19 |
Alejandro Muñoz-Jiménez, Esteban Rubio-Romero, José Luis Marenco de la Fuente |
29 |
[GO] |
2021―Mrz―23 |
Safety in the use of ultrasound in rheumatology during the COVID-19 Pandemic. Spanish Society of Rheumatology positioning paper |
Lucía Mayordomo, Juan Molina Collada, Félix M. Francisco Hernández, Ángel Bueno, Santos A. Insua Vilariño, Francisco Gabriel Jiménez-Núñez, et al. (+8) Rosalía Martínez Pérez, Ingrid Möller, Jacqueline Usón Jaeger, José Francisco García-Llorente, José M. Álvaro-Gracia, Eduardo Aparicio Ruiz, Liliana Asaro Daverio, Esperanza Naredo |
30 |
[GO] |
2020―Okt―16 |
SARS-CoV-2 (COVID-19) in Patients with some Degree of Immunosuppression |
Jairo Cajamarca-Baron, Diana Guavita-Navarro, Jhon Buitrago-Bohorquez, Laura Gallego-Cardona, Angela Navas, Hector Cubides, et al. (+3) Ana María Arredondo, Alejandro Escobar, Adriana Rojas-Villarraga |
31 |
[GO] |
2020―Okt―15 |
Reumataxi: An experience of solidarity in times of COVID-19 |
Josep Blanch-Rubió, Jone Llorente-Onaindia, Pere Benito, Jordi Monfort |
32 |
[GO] |
2020―Okt―15 |
Inflammatory Response in Relation to COVID-19 and Other Prothrombotic Phenotypes |
José A. Páramo |
33 |
[GO] |
2020―Okt―15 |
Therapeutic Options for the Management of Severe COVID-19: A Rheumatology Perspective |
Claudia Mendoza-Pinto, Mario García-Carrasco, Pamela Munguía Realpozo, Socorro Méndez-Martínez |
34 |
[GO] |
2020―Okt―15 |
COVID-19: overview of rheumatology fellows |
Andrea Garcia-Guillén, Sicylle Jeria, David Lobo-Prat, Luís Sainz, Hèctor Corominas |
35 |
[GO] |
2020―Okt―15 |
Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab |
Luis Figuero-Pérez, Alejandro Olivares-Hernández, Roberto A. Escala-Cornejo, Eduardo Terán-Brage, Álvaro López-Gutiérrez, Juan J. Cruz-Hernández |
36 |
[GO] |
2020―Okt―09 |
Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology |
Lina María Saldarriaga Rivera, Daniel Fernández Ávila, Wilson Bautista Molano, Daniel Jaramillo Arroyave, Alain Jasaf Bautista Ramírez, Adriana Díaz Maldonado, et al. (+5) Jorge Hernán Izquierdo, Edwin Jáuregui, María Constanza Latorre Muñoz, Juan Pablo Restrepo, Juan Sebastián Segura Charry |
37 |
[GO] |
2020―Jun―17 |
COVID-19 with Pulmonary Involvement. An Autoimmune Disease of Known Cause |
Benjamin Fernandez-Gutierrez |